Evaluation of neuroprotective properties of Ademol with experimental traumatic brain injury conditions


  • S. I. Semenenko National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • O. A. Khodakivsky National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • O. M. Semenenko National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • O. O. Yakovleva National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • N. O. Semenenko National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: traumatic brain injury, Ademol, rats

Abstract

The choice of drugs in traumatic injuries of the head is one of the most complex problems in the complex treatment of such patients. The aim was to estimate the cerebroprotective action of Ademol on the indicator of lethality of rats against the background of an experimental traumatic brain injury (TBI). The experimental model of the TBI of severe severity was caused by the action of the flow of carbon dioxide under pressure that was created using a gas cylinder pneumatic gun. The therapeutic effect of Ademol on the model TBI was evaluated at doses of 1, 2 and 4 mg/kg intravenously. Pseudo-operative animals and control group received a 0.9% NaCl solution at a dose of 2 ml/kg. The results were processed using the statistical program StatPlus 2009. Used Fisher angular transformation when accounting for results in an alternative form. In the course of the experiment, it was found that in the control group at the end of the experiment, 8 days after the TBI model, death of 90% of the rats was recorded p<0.05. Ademol showed the highest protective effect on the brain at a dose of 2 mg/kg where the death of rats was 30% on the 8th day of the experiment. The obtained data indicate that among the studied doses 1; 2 and 4 mg/kg is conventionally effective at just 2 mg/kg, in which Ademol exhibited the highest neuroprotective activity (p<0.05).

References

1. Han, J., Yang, F., Jiang, W., Zhang, G., Liu, Z., Liu, X., … Zhao, G. (2012). Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion. BMC Neurol, 12, 127–135.

2. Lehmann, L., Bendel, S., Uehlinger, D.E., Takala, J., Schafer, M., Reinert, M., & Jakob, S. M. (2013). Randomized, double-blind trial of the effect of fluid composition on electrolyte, acid base, and fluid homeostasis in patients early after subarachnoid hemorrhage. Neurocrit. Care, 18 (1), 5–12.

3. Li, C. Y., Karmarkar, A., Adhikari, D., Ottenbacher, K., & Kuo, Y. F. (2018). Effects of Age and Sex on Hospital Readmission in Traumatic Brain Injury. Arch Phys Med Rehabil, 17, 1466–1471.

4. Oddo, M., Poole, D., Helbok, R., Meyfroidt, G., Stocchetti, N., Bouzat, P., … Citerio, G. (2018). Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations. Intensive Care Med, Mar 2. doi: 10.1007/s00134-018-5086-z.

5. Semenenko, A. I. (2013). Dynamics of activity of neuron-specific enolase and the content of S100 protein in blood of rats in conditions of acute cerebrovascular accident and course administration of 0.9% NaCl. Pharmacology and drug toxicology, 6 (36), 9–13.
Published
2019-06-27
How to Cite
Semenenko, S. I., Khodakivsky, O. A., Semenenko, O. M., Yakovleva, O. O., & Semenenko, N. O. (2019). Evaluation of neuroprotective properties of Ademol with experimental traumatic brain injury conditions. Reports of Vinnytsia National Medical University, 23(2), 209-211. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2019-23(2)-04